ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,420,000 | -57.0% | 25,000 | -66.7% | 0.02% | -52.5% |
Q2 2021 | $3,301,000 | +21.7% | 75,000 | +36.4% | 0.04% | +21.2% |
Q1 2021 | $2,713,000 | -50.1% | 55,000 | -57.4% | 0.03% | +13.8% |
Q4 2020 | $5,440,000 | +164.1% | 129,200 | +187.1% | 0.03% | -6.5% |
Q3 2020 | $2,060,000 | +765.5% | 45,000 | +848.2% | 0.03% | +675.0% |
Q2 2020 | $238,000 | – | 4,746 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |